Swisstek (Ceylon) Bilan de santé

Santé financière contrôle des critères 3/6

Swisstek (Ceylon) possède un total de capitaux propres de LKR2.7B et une dette totale de LKR6.4B, ce qui porte son ratio d'endettement à 236.9%. Son actif total et son passif total sont LKR12.0B et de LKR9.3B. L'EBIT de Swisstek (Ceylon) est LKR1.2B ce qui fait que son ratio de couverture des intérêts 3.4. Elle dispose de liquidités et de placements à court terme de LKR419.1M.

Informations clés

236.9%

Ratio d'endettement

LK₨6.35b

Dette

Ratio de couverture des intérêts	3.4x
Argent liquide	LK₨419.13m
Fonds propres	LK₨2.68b
Total du passif	LK₨9.34b
Total des actifs	LK₨12.03b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de PARQ.N0000 ( LKR7.6B ) dépassent ses passifs à court terme ( LKR6.7B ).

Passif à long terme: Les actifs à court terme de PARQ.N0000 ( LKR7.6B ) dépassent ses passifs à long terme ( LKR2.6B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de PARQ.N0000 ( 221.3% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de PARQ.N0000 est passé de 150.1% à 236.9% au cours des 5 dernières années.

Couverture de la dette: La dette de PARQ.N0000 n'est pas bien couverte par le flux de trésorerie opérationnel ( 3.4% ).

Couverture des intérêts: Les paiements d'intérêts de PARQ.N0000 sur sa dette sont bien couverts par l'EBIT ( 3.4 x couverture).

Swisstek (Ceylon) Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Second quarter 2025 earnings released: EPS: LK₨1.63 (vs LK₨0.055 in 2Q 2024)

Investor sentiment improves as stock rises 18%

MD & Executive Director recently bought LK₨2.0m worth of stock

Investor sentiment improves as stock rises 18%

First quarter 2025 earnings released: EPS: LK₨0.58 (vs LK₨1.16 loss in 1Q 2024)

Upcoming dividend of LK₨0.30 per share

Full year 2024 earnings released: LK₨0.51 loss per share (vs LK₨4.15 loss in FY 2023)

Dividend of LK₨0.30 announced

New minor risk - Share price stability

Upcoming dividend of LK₨0.50 per share

Dividend reduced to LK₨0.50

Third quarter 2024 earnings released: LK₨0.43 loss per share (vs LK₨1.99 loss in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.16 loss per share (vs LK₨0.12 profit in 2Q 2023)

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: LK₨1.16 loss per share (vs LK₨0.28 loss in 1Q 2023)

Upcoming dividend of LK₨0.20 per share at 7.7% yield

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 30, 2023

Swisstek (Ceylon) plc Proposes Final Dividend

Full year 2023 earnings released: LK₨4.15 loss per share (vs LK₨6.16 profit in FY 2022)

MD & Executive Director recently bought LK₨463k worth of stock

Third quarter 2023 earnings released: LK₨1.99 loss per share (vs LK₨2.41 profit in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: EPS: LK₨0.12 (vs LK₨1.40 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Director recently bought LK₨4.3m worth of stock

First quarter 2023 earnings released: LK₨0.28 loss per share (vs LK₨0.49 profit in 1Q 2022)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨274k worth of stock

Investor sentiment improved over the past week

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 29, 2022

Upcoming dividend of LK₨0.90 per share

Full year 2022 earnings released: EPS: LK₨6.16 (vs LK₨4.37 in FY 2021)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨150k worth of stock

Investor sentiment deteriorated over the past week

Insufficient new directors

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of LK₨1.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

MD & Executive Director recently bought LK₨232k worth of stock

Director recently sold LK₨16m worth of stock

Director recently sold LK₨16m worth of stock

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Upcoming dividend of LK₨0.80 per share

Director recently bought LK₨7.0m worth of stock

First quarter 2022 earnings released: EPS LK₨0.49 (vs LK₨0.21 loss in 1Q 2021)

Full year 2021 earnings released: EPS LK₨4.37 (vs LK₨1.26 in FY 2020)

Investor sentiment deteriorated over the past week

Director recently sold LK₨12m worth of stock

Upcoming Dividend of LK₨4.10 Per Share

Third quarter 2021 earnings released: EPS LK₨6.04 (vs LK₨2.28 in 3Q 2020)

Investor sentiment improved over the past week

New 90-day high: LK₨141

New 90-day high: LK₨101

New 90-day high: LK₨85.20

Director recently sold LK₨8.0m worth of stock

Market bids up stock over the past week

Second quarter 2021 earnings released: EPS LK₨5.51

New 90-day high: LK₨68.20

Market bids up stock over the past week

MD & Executive Director recently bought LK₨817k worth of stock

Market bids up stock over the past week

New 90-day high: LK₨51.10

New 90-day high: LK₨46.50

New 90-day high - LK₨43.50

First quarter earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines